Dr Lalchandani Labs Profile
Key Indicators
- Authorised Capital ₹ 4.50 Cr
as on 04-07-2024
- Paid Up Capital ₹ 4.33 Cr
as on 04-07-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.64 Cr
as on 04-07-2024
- Satisfied Charges ₹ 1.20 Cr
as on 04-07-2024
- Revenue -55.27%
(FY 2023)
- Profit -267.45%
(FY 2023)
- Ebitda -96.53%
(FY 2023)
- Net Worth -14.91%
(FY 2023)
- Total Assets -2.23%
(FY 2023)
About Dr Lalchandani Labs
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 541299.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 Cr and a paid-up capital of Rs 4.33 Cr.
The company currently has active open charges totaling ₹2.64 Cr. The company has closed loans amounting to ₹1.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Dr Lalchandani Labs Limited India are Anchal Gupta as CFO and Karan Kumar as Company Secretary. Arjan Chandani, Anchal Gupta, Mohit Chandani, and Three other members serve as directors at the Company.
- CIN/LLPIN
L85320DL2017PLC321605
- Company No.
321605
- Stock Symbol
BSE : 541299
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr Lalchandani Labs?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anchal Gupta  | CFO | 01-Nov-2019 | Current |
| Arjan Chandani | Managing Director | 02-Aug-2017 | Current |
| Karan Kumar | Company Secretary | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohit Chandani | Whole-Time Director | 02-Aug-2017 | Current |
| Anchal Gupta | Director and Cfo | 02-Aug-2017 | Current |
| Rajiv Handa | Director | 27-Dec-2017 | Current |
| Prakash Jhuraney | Director | 02-Nov-2018 | Current |
| Swati Chandra | Director | 09-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of Dr Lalchandani Labs.
Dr Lalchandani Labs Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 55.27% decrease. The company also saw a substantial fall in profitability, with a 267.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Lalchandani Labs?
In 2021, Dr Lalchandani Labs had a promoter holding of 60.78% and a public holding of 39.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
28 years 2 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Nov 2020 | ₹2.64 Cr | Open |
Others Creation Date: 14 Aug 2019 | ₹1.00 Cr | Satisfied |
Others Creation Date: 29 Jun 2019 | ₹2.00 M | Satisfied |
How Many Employees Work at Dr Lalchandani Labs?
Dr Lalchandani Labs has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of May 05, 2018, Dr Lalchandani Labs has raised a total of ₹ 6.55 Cr, with the most recent deal valued at ₹ 4.2 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
